FDA inspection
Shenzhen Hepalink Pharmaceutical Co., Ltd.: FDA inspection ending Jan 13, 2020
FDA inspection 1134048 · Voluntary Action Indicated (VAI) · Shenzhen
Key facts
| Inspection ID | 1134048 |
|---|---|
| Firm | Shenzhen Hepalink Pharmaceutical Co., Ltd. |
| FEI number | 3002808210 |
| Address | 21 LangShan Road, Songpingshan, Nanshan district |
| City | Shenzhen |
| Country | China |
| Fiscal year | 2020 |
| Inspection end date | Jan 13, 2020 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data